Integer (NYSE:ITGR – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Benchmark in a research note issued to investors on Friday, Benzinga reports. They currently have a $130.00 price target on the medical equipment provider’s stock. Benchmark’s target price points to a potential upside of 19.74% from the company’s previous […]